Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) - Total Assets
Based on the latest financial reports, Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) holds total assets worth ₫2.69 Trillion VND (≈ $102.11 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore DBD cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Binh Dinh Pharmaceutical and Medical Equipment JSC - Total Assets Trend (2020–2025)
This chart illustrates how Binh Dinh Pharmaceutical and Medical Equipment JSC's total assets have evolved over time, based on quarterly financial data. See Binh Dinh Pharmaceutical and Medical Equ net assets for net asset value and shareholders' equity analysis.
Binh Dinh Pharmaceutical and Medical Equipment JSC - Asset Composition Analysis
Current Asset Composition (December 2025)
Binh Dinh Pharmaceutical and Medical Equipment JSC's total assets of ₫2.69 Trillion consist of 57.3% current assets and 42.7% non-current assets.
| Asset Category | Amount (VND) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₫0.00 | 7.9% |
| Accounts Receivable | ₫495.35 Billion | 19.2% |
| Inventory | ₫366.11 Billion | 14.2% |
| Property, Plant & Equipment | ₫0.00 | 0.0% |
| Intangible Assets | ₫85.03 Billion | 3.3% |
| Goodwill | ₫0.00 | 0.0% |
Asset Composition Trend (2020–2025)
This chart illustrates how Binh Dinh Pharmaceutical and Medical Equipment JSC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Binh Dinh Pharmaceutical and Medical Equ market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Binh Dinh Pharmaceutical and Medical Equipment JSC's current assets represent 57.3% of total assets in 2025, a decrease from 58.2% in 2020.
- Cash Position: Cash and equivalents constituted 7.9% of total assets in 2025, up from 7.6% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 4.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 19.2% of total assets.
Binh Dinh Pharmaceutical and Medical Equipment JSC Competitors by Total Assets
Key competitors of Binh Dinh Pharmaceutical and Medical Equipment JSC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Suven Pharmaceuticals Limited
NSE:SUVENPHAR
|
India | Rs30.32 Billion |
|
Neuland Laboratories Limited
NSE:NEULANDLAB
|
India | Rs29.30 Billion |
|
Bausch Health Companies Inc
TO:BHC
|
Canada | CA$24.50 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.84 Billion |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550
|
China | CN¥3.23 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
|
Shandong Lukang Pharmaceutical Co Ltd
SHG:600789
|
China | CN¥9.88 Billion |
|
Heilongjiang ZBD Pharmaceutical Co Ltd
SHG:603567
|
China | CN¥11.80 Billion |
Binh Dinh Pharmaceutical and Medical Equipment JSC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.99 | 4.06 | 3.44 |
| Quick Ratio | 2.17 | 2.73 | 2.42 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₫1.02 Trillion | ₫1.07 Trillion | ₫777.33 Billion |
Binh Dinh Pharmaceutical and Medical Equipment JSC - Advanced Valuation Insights
This section examines the relationship between Binh Dinh Pharmaceutical and Medical Equipment JSC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.63 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 14.1% |
| Total Assets | ₫2.58 Trillion |
| Market Capitalization | $178.06 Million USD |
Valuation Analysis
Below Book Valuation: The market values Binh Dinh Pharmaceutical and Medical Equipment JSC's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Binh Dinh Pharmaceutical and Medical Equipment JSC's assets grew by 14.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Binh Dinh Pharmaceutical and Medical Equipment JSC (2020–2025)
The table below shows the annual total assets of Binh Dinh Pharmaceutical and Medical Equipment JSC from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₫2.58 Trillion ≈ $98.18 Million |
+14.13% |
| 2024-12-31 | ₫2.26 Trillion ≈ $86.03 Million |
+13.84% |
| 2023-12-31 | ₫1.99 Trillion ≈ $75.57 Million |
+4.92% |
| 2022-12-31 | ₫1.90 Trillion ≈ $72.03 Million |
+21.56% |
| 2021-12-31 | ₫1.56 Trillion ≈ $59.25 Million |
+8.50% |
| 2020-12-31 | ₫1.44 Trillion ≈ $54.61 Million |
-- |
About Binh Dinh Pharmaceutical and Medical Equipment JSC
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company manufactures and trades in pharmaceuticals and medical equipment in Vietnam. It offers antibiotics; anticancer drugs; hemodialysis solutions; hepatobiliary drugs; analgesic and antipyretic drugs; drugs for muscles, bones, and joints; antihistamine anti-allergy drugs; ear, eye, nose, and throat drops; cardiovascular drugs; nervous … Read more